FormWeb • emtricitabine-rilpivirine-tenofovir

Non-Formulary Order	Formulary Equivalent Order
Rilpivirine 25 mg/emtricitabine 200 mg/TDF 300 mg (Complera) combination tablet	Equivalent dose of rilpivirine + emtricitabine/TDF

Caution – Category 2: Non-antineoplastic Risk Hazardous Medication, see below for exposure mitigation strategies

Emtricitabine-rilpivirine-tenofovir (Complera; Odefsey) is not on the UNC Health Medication Formulary and is not readily available to dispense for hospital or clinic use. Requests for use in the hospital or clinic must go through non-formulary, patient-supplied, or other pathways, as appropriate. Outpatient prescriptions for this medication may be filled through specialty retail pharmacies, such as the UNC SSC Specialty Pharmacy, pending insurance approval.

You may contact the UNC SSC Specialty Pharmacy toll free at 855-788-4101 (option 4) or visit the website at https://www.uncmedicalcenter.org/uncmc/patients-visitors/amenities/pharmacies/specialty-pharmacy-service/

Last updated: Jul. 18, 2023

This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.